Earendil Labs
Latest round
- Series E
Last raised
- Mar 2026
Total raised
- $185M
Investors
- 7
About Earendil Labs
Founded in 2024 in New York, US, Earendil Labs Inc focuses on applying artificial intelligence to advance drug discovery for protein therapeutics.Earendil Labs specializes in the development of advanced AI platforms specifically designed to revolutionize protein therapeutics research and development. Their core offerings focus on utilizing artificial intelligence to discover and develop novel drugs, addressing critical challenges in the pharmaceutical industry, such as the need for more effective and targeted therapies. The company's technology aims to streamline the drug discovery process, ultimately reducing time and costs associated with bringing new therapeutics to market. Earendil Labs serves a diverse client base that includes biotechnology firms, pharmaceutical companies, and research institutions, primarily targeting markets in North America, Europe, and Asia.Earendil Labs generates revenue through strategic partnerships and collaborations with various stakeholders in the healthcare and pharmaceutical sectors. Business transactions typically involve B2B agreements, where the company licenses its AI technology to clients for drug discovery projects. These partnerships can include subscription-based models, allowing clients to access proprietary software tools and algorithms that enhance their research capabilities. In addition, revenue may also stem from milestone payments tied to the successful development of drug candidates that utilize their platforms. The company plans to launch new products designed to further enhance drug discovery capabilities, while targeting expansion into new markets across Europe and Asia by 2027.
Who invested in Earendil Labs
7 investors across 1 round
See all investors in Earendil Labs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Mar 25, 2026
Amount
$185M
Investors
Questions about Earendil Labs
Who invested in Earendil Labs?
Earendil Labs has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Earendil Labs raised?
Earendil Labs has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Earendil Labs last raise money?
Earendil Labs's most recent round on record is a Series E, in Mar 2026.
What does Earendil Labs do?
Founded in 2024 in New York, US, Earendil Labs Inc focuses on applying artificial intelligence to advance drug discovery for protein therapeutics.
Where is Earendil Labs headquartered?
Earendil Labs is headquartered in New York, US.
Which VCs invest in companies like Earendil Labs?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Earendil Labs's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Earendil Labs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.